Alteration in the IL‐2 signal peptide affects secretion of proteins in vitro and in vivo
Authors:
- 23 December 2004
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 7 (3) , 354-365
Abstract
Background: Although hundreds of different signal peptides have now been identified, few studies have examined the factors enabling signal peptides to augment secretion of mature proteins. Signal peptides, located at the N‐terminus of nascent secreted proteins, characteristically have three domains: (1) a basic domain at the N‐terminus, (2) a central hydrophobic core, and (3) a carboxy‐terminal cleavage region. In this study, we investigated whether alterations in the basic and/or the hydrophobic domains of a commonly used signal peptide from interleukin‐2 (IL‐2) affected secretion of two proteins: placental alkaline phosphatase (AP) and endostatin.Methods: A series of modifications in the basic and/or hydrophobic domains of the IL‐2 signal peptide were made by polymerase chain reaction with endostatin or AP plasmids as templates. Transfection of wild‐type or modified IL‐2 signal peptides fused in‐frame with endostatin or AP were done with Superfect in vitro or by the hydrodynamic method in vivo.Results: Increasing both the basicity and hydrophobicity of the signal peptide augmented the secretion of AP and endostatin by approximately 2.5‐ and 3.5‐fold, respectively, from MDA‐MB‐435 cells in vitro. Over a range of DNA concentrations and times, the most effective IL‐2 signal peptide increased AP levels in the medium compared to the wild‐type IL‐2 signal peptide. Comparable results from these modified IL‐2 signal peptides were found to increase AP levels in the medium from bovine aortic endothelial cells. Moreover, the combined changes in basic and hydrophobic domains of the IL‐2 signal peptide augmented serum levels of endostatin and placental AP by 3‐fold when the optimal plasmid constructs were injected in vivo.Conclusions: Modification of the IL‐2 signal peptide augments protein secretion both in vitro and in vivo. As a result, optimizing the signal peptide should be considered for increasing the therapeutic levels of secreted proteins. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 40 references indexed in Scilit:
- Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritisGene Therapy, 2001
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorNature Genetics, 2000
- The Amino-terminal Charge and Core Region Hydrophobicity Interdependently Contribute to the Function of Signal SequencesJournal of Biological Chemistry, 1996
- Physical and Conformational Properties of Synthetic Idealized Signal Sequences Parallel Their Biological FunctionBiochemistry, 1995
- Signal sequencesBiochemistry, 1989
- Idealization of the hydrophobic segment of the alkaline phosphatase signal peptideNature, 1986
- Signal sequencesJournal of Molecular Biology, 1985
- A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptidesJournal of Molecular Biology, 1983
- Predicted secondary structures of amino‐terminal extension sequences of secreted proteinsFEBS Letters, 1979
- Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma.Journal of Cell Biology, 1975